C21 Investments Inc. (CSE: CXXI)

Market Cap	36.01M
Revenue (ttm)	n/a
Net Income (ttm)	n/a
Shares Out	120.05M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,850
Open	0.310
Previous Close	0.270
Day's Range	0.295 - 0.310
52-Week Range	0.205 - 0.640
Beta	2.30
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About C21 Investments

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cured resin, and CBD CO2 vaporizer pens; live, cured, and CBD cured resin extracts; bulk, wholesale, and packaged flowers; edibles; pre-rolls; tinctures; and topicals. It also provides payroll and benefits services. The company was formerly known as Curlew Lake Resources Inc. and changed its name to C21 Investments Inc. in Novembe...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 114
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CXXI

Financial Performance

In 2023, C21 Investments's revenue was $26.79 million, a decrease of -5.29% compared to the previous year's $28.29 million. Losses were -$446,424, -86.49% less than in 2023.

Financial numbers in USD